Summary of Key Points
DRG/DIP 3.0 is not merely about “more detailed disease categorization”; it represents a “restructuring of the rules” for healthcare payment reform. Through three key measures—uniform payment for the same disease at the grassroots level and in large hospitals, decoupling doctor performance from payment, and creating pathways for innovative technologies—it redefines how hospitals generate revenue, how doctors are compensated, and how new technologies can be integrated into the healthcare system. Once implemented nationwide by March 2027, large hospitals, grassroots institutions, doctors, and the entire healthcare industry will need to adapt to this new methodology of cost allocation.
Detailed Explanation
1. Uniform pricing for primary and tertiary care: Can this encourage patients to seek treatment for common illnesses at community clinics?
For the first time, DRG/DIP 3.0 has identified 158 “primary care diseases” (such as the common cold, hypertension monitoring, and diabetes management). Regardless of whether the treatment is received at a community clinic or a top-tier hospital, the amount paid by healthcare insurance will be the same (uniform payment for the same disease). The government’s goal is clear: to encourage people to treat minor and common illnesses at community clinics, freeing up large hospitals to focus on more serious cases (a system of tiered healthcare).
However, there are two practical challenges:
- Local flexibility: The list is meant as a guide, not a mandatory requirement, and local authorities can adjust it according to their available medical resources;
- Capacity at the grassroots level: With the same amount of funding, if community doctors lack the necessary skills or if treatment outcomes are poor (e.g., complications), the cost may be higher than at large hospitals.
On the positive side, this creates opportunities for industry developments, such as the promotion of county-level healthcare partnerships and AI-based follow-up tools, as there is now financial support for their implementation.
2. Doctors no longer have to worry about losing wages due to overspending?
Previously, many hospitals used the insurance payment standards as a limit on doctors’ compensation. DRG/DIP 3.0 explicitly states that hospitals cannot link these standards to doctors’ performance. If hospitals manage to reduce costs, the surplus funds can be used for performance incentives or to support research and development.
This approach aims to:
- Prevent abuse: Hospitals cannot artificially categorize common illnesses as more expensive ones (e.g., misclassifying a cold as pneumonia) to increase revenue;
- Incentivize cost savings: It encourages hospitals to save costs effectively, rather than forcing doctors to use fewer medications or discharge patients more quickly.
However, this does not equate to a salary increase; it simply ensures that doctors are not unfairly penalized for providing proper care.
3. Surgical robots and new medications finally have a chance to be covered by insurance?
Innovative technologies often faced barriers due to lack of insurance coverage. DRG/DIP 3.0 provides two pathways:
- Specialized categories: A separate category for robot-assisted surgeries has been established, allowing these procedures to be paid according to their own standards;
- Exceptional cases: For complex cases involving expensive or new technologies (e.g., cancer treatment with targeted drugs or complex surgeries), separate reimbursement applications can be made (with maximum reimbursement limits of 5% for DRG and 1% for DIP).
While this offers reassurance to innovative companies, the scope of coverage is limited, as only a few challenging cases will qualify.
4. More precise disease categorization requires hospitals to re-evaluate their cost structures:
The reorganization of disease categories is significant: the number of DRG groups has increased from 409 to 492, and the number of DIP categories has decreased from 9,520 to 5,125, with improved accuracy in disease identification. This means hospitals need to adjust their strategies:
- Large tertiary hospitals: Cannot rely on performing more routine surgeries; they must focus on high-value, complex procedures;
- County-level hospitals: Must identify their own areas of expertise and stop competing with community clinics for common patients;
- Grassroots hospitals: With the same payment standards as large hospitals, they need to improve their technical capabilities to attract patients;
- Industry players: Companies providing cost analysis, coding services, and integration with insurance systems (e.g., grouping systems and big data platforms) will play a crucial role, as hospitals urgently need help in managing their financial operations more effectively.
In conclusion
DRG/DIP 3.0 is not just a document aimed at controlling costs; it represents a fundamental reshaping of the healthcare industry’s rules. Those who can adapt to the new cost-allocation logic will have a better chance of thriving in the future healthcare market.